Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 84 (RPL23AP84)
- Target
- RPL23AP84
- Molecular classification
- Other, Pseudogene
01
Overview
Ribosomal protein L23a pseudogene 84 (RPL23AP84) is one of many pseudogenes derived from the ribosomal protein L23a gene family[1]. As a pseudogene, RPL23AP84 does not code for a functional protein and is generally considered non-coding. There are no data supporting its role as a therapeutic target, nor is it described as a receptor, enzyme, transporter, or transcription factor. Its biological and clinical relevance is unclear, and there are no known drugs, biomarkers, or mechanisms of drug action linked to this locus. Furthermore, there is no evidence to suggest a role in disease or pathology. The canonical RPL23A gene encodes a component of the large 60S ribosomal subunit, but RPL23AP84 itself is classified as a non-functional genomic element[1].
- Other names
- RPL23AP84Ribosomal protein L23a pseudogene 84
02
Biological functions
Other (no known functional protein product)
03
Disease associations
Other (no direct disease association established for this pseudogene; not a validated disease gene)
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 84 (RPL23AP84).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 84 (RPL23AP84).